Prosight Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-63,524
Closed -$772K 32
2022
Q1
$772K Buy
+63,524
New +$1.34M 0.5% 26
2020
Q3
Sell
-38,819
Closed -$1.2M 55
2020
Q2
$1.2M Buy
+38,819
New +$1.08M 0.52% 41

Other funds holding NEO

Prosight Management's NEO Position: Q2 2022 in Review

Prosight Management sold out of NeoGenomics (NEO) in Q2 2022, closing a stake of 63,524 shares — an estimated $772K sold.

Prosight Management first reported a position in NEO in Q2 2020 and held it in 2 quarters. The position peaked at $1.2M in Q2 2020. 239 funds tracked by Wall St. Rank hold NEO as of Q2 2022.

  • Prosight Management reported no remaining NeoGenomics position as of Q2 2022 after selling out during the quarter.
  • Prosight Management sold 63,524 NeoGenomics shares in Q2 2022, an estimated $772K.
  • Prosight Management first reported a position in NeoGenomics in Q2 2020 and held it in 2 quarters.
  • Prosight Management's NeoGenomics position peaked at $1.2M in Q2 2020.
  • 239 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2022.

Based on Prosight Management's 13F filing for Q2 2022, filed 12 Aug 2022.